基础医学与临床 ›› 2011, Vol. 31 ›› Issue (1): 84-88.

• 技术与方法 • 上一篇    下一篇

一种HCV靶向性M1GS核酶的构建及其体外活性

张文军1,刘碧瑜1,周玉珍1,林桂先1,张欣2,李红枝1   

  1. 1. 广东药学院2. 暨南大学
  • 收稿日期:2010-04-29 修回日期:2010-07-19 出版日期:2011-01-05 发布日期:2011-01-05
  • 通讯作者: 李红枝

Construction of an effective M1GS ribozyme targeting to HCV genome and its cleavage activity in vitro

ZHANG Wen-jun 1,LIU Bi-yu 2,ZHOU Yu-zhen 2,LIN Gui-xian 2,ZHANG Xin 2,LI Hong-zhi 1   

  1. 1. Guangdong Pharmaceutical University2.
  • Received:2010-04-29 Revised:2010-07-19 Online:2011-01-05 Published:2011-01-05
  • Contact: LI Hong-zhi

摘要: 目的 构建对HCV基因组具有特异切割作用的新型靶向性核酶—M1GS。方法 针对HCV基因组的保守区(5ˊUTR)设计并合成一段引导序列,通过PCR扩增直接将该引导序列连接于大肠杆菌核糖核酸酶P的催化亚基(M1 RNA)的3ˊ末端,从而构建一类靶向性M1GS核酶。 结果 体外切割实验表明,所构建的核酶(M1GS-HCV/C67)对HCV 5ˊUTR具有明显的切割作用,切割的位点在靶序列67nt-68nt之间,属于特异性切割。结论 本文构建了一种对HCV 5’UTR具有靶向切割活性的M1GS核酶,为胞内反义效应及动物模型内抗病毒效应的评价提供了实验材料,为新型抗HCV药物的研究奠定了基础。

关键词: 丙型肝炎病毒, 5’非翻译区, 核酶P, 靶向切割

Abstract: Objective To construct a targeting ribozyme (M1GS) which is specific to HCV genome. Methods According to the sequence of conservative sequence (5ˊUTR) of HCV genome, a guide sequence was designed and synthesized. And then by the PCR method, a kind of targeting ribozyme can be constructed by covalently linking the guide sequence to the 3ˊterminus of M1 RNA, the catalytic subunit of RNase P from Escherichia coli. Results The engineered ribozyme(M1GS-HCV/C67) is targeted to the 5ˊUTR of HCV genome, and can effectively cleave the substrate RNA segment in vitro. The cleavage is specific and the cleavage site is between 67nt and 68nt of the target region. Conclusion The M1GS-HCV/C67 we got here would be a useful experimental material to further study its cleavage activity in vivo, and can be even used for evaluating its anti-viral effect in the animal model. It was believed that this study would markedly facilitate the research of a general gene targeting agent for anti-HCV applications, and layed the foundation for developing a new nucleic acid drug of anti-HCV therapy.